Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Other Non-Current Assets (2015 - 2026)

Mesoblast's (MEOBF) quarterly Other Non-Current Assets came in at $1.2 million in Q2 2026, down 7.1% year-over-year from $1.3 million in Q2 2025, and up 0.84% quarter-over-quarter from $1.2 million in Q4 2025.

Analysis

Mesoblast (MEOBF) Other Non-Current Assets (2015 - 2026) Analysis & Trends

Mesoblast has disclosed Other Non-Current Assets across 12 years of filings, most recently posting $1.2 million for Q2 2026.

  • In Q2 2026, Other Non-Current Assets fell 7.1% year-over-year to $1.2 million; the TTM figure through Jun 2026 stood at $1.2 million (down 7.1% YoY), while the FY2026 annual figure was $1.2 million, down 7.1% from the prior year.
  • Other Non-Current Assets came in at $1.2 million for Q2 2026 at Mesoblast, up from $1.2 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $2.4 million in Q1 2023 to a low of $397000.0 in Q2 2024.
  • Average Other Non-Current Assets over 5 years is $1.4 million, with a median of $1.3 million recorded in 2024.
  • Year-over-year, Other Non-Current Assets slumped 40.52% in 2024 and soared 226.45% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $1.9 million in 2022, then grew by 16.6% to $2.2 million in 2023, then tumbled by 40.52% to $1.3 million in 2024, then fell by 10.43% to $1.2 million in 2025, then increased by 0.84% to $1.2 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $1.2 million in Q2 2026, $1.2 million in Q4 2025, and $1.3 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn 284,000.00
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - 37.71 Mn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn 6.43 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 25.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 4.54 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - 7.86 Mn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 708,000.00
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn 146.15 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 233,000.00
10 Mesoblast 246.02 Mn 143.11 Mn - 1.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.20 Mn
Dec 31, 2025 1.19 Mn
Jun 30, 2025 1.30 Mn
Dec 31, 2024 1.33 Mn
Jun 30, 2024 397,000.00
Dec 31, 2023 2.24 Mn
Jun 30, 2023 398,000.00
Mar 31, 2023 2.39 Mn
Dec 31, 2022 1.92 Mn
Sep 30, 2022 1.90 Mn
Jun 30, 2022 413,000.00
Mar 31, 2022 1.97 Mn
Dec 31, 2021 1.96 Mn
Sep 30, 2021 1.95 Mn
Jun 30, 2021 451,000.00
Mar 31, 2021 3.20 Mn
Dec 31, 2020 3.21 Mn
Sep 30, 2020 3.33 Mn
Jun 30, 2020 3.31 Mn
Mar 31, 2020 3.24 Mn